1. Home
  2. ADAG vs CURR Comparison

ADAG vs CURR Comparison

Compare ADAG & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • CURR
  • Stock Information
  • Founded
  • ADAG 2011
  • CURR 2013
  • Country
  • ADAG China
  • CURR Singapore
  • Employees
  • ADAG N/A
  • CURR N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • CURR Business Services
  • Sector
  • ADAG Health Care
  • CURR Consumer Discretionary
  • Exchange
  • ADAG Nasdaq
  • CURR Nasdaq
  • Market Cap
  • ADAG 91.2M
  • CURR 89.8M
  • IPO Year
  • ADAG 2021
  • CURR N/A
  • Fundamental
  • Price
  • ADAG $2.10
  • CURR $1.34
  • Analyst Decision
  • ADAG Strong Buy
  • CURR
  • Analyst Count
  • ADAG 1
  • CURR 0
  • Target Price
  • ADAG $5.00
  • CURR N/A
  • AVG Volume (30 Days)
  • ADAG 89.6K
  • CURR 10.5K
  • Earning Date
  • ADAG 07-25-2024
  • CURR 02-11-2025
  • Dividend Yield
  • ADAG N/A
  • CURR N/A
  • EPS Growth
  • ADAG N/A
  • CURR N/A
  • EPS
  • ADAG N/A
  • CURR N/A
  • Revenue
  • ADAG $815,746.00
  • CURR $55,500,917.00
  • Revenue This Year
  • ADAG N/A
  • CURR N/A
  • Revenue Next Year
  • ADAG $2.70
  • CURR N/A
  • P/E Ratio
  • ADAG N/A
  • CURR N/A
  • Revenue Growth
  • ADAG N/A
  • CURR N/A
  • 52 Week Low
  • ADAG $1.44
  • CURR $1.20
  • 52 Week High
  • ADAG $4.38
  • CURR $5.74
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 44.51
  • CURR N/A
  • Support Level
  • ADAG $2.02
  • CURR N/A
  • Resistance Level
  • ADAG $2.25
  • CURR N/A
  • Average True Range (ATR)
  • ADAG 0.27
  • CURR 0.00
  • MACD
  • ADAG -0.00
  • CURR 0.00
  • Stochastic Oscillator
  • ADAG 27.08
  • CURR 0.00

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants worldwide, delivering frictionless interoperable real-time fund transfers and instant messaging.

Share on Social Networks: